IMVT R&D Expenses
Immunovant Inc · R&D Expenses
IMVT R&D Expenses
Latest reported$142.63Mperiod ending
IMVT Quarterly R&D Expenses ($4.34M → $142.63M)
Quarterly R&D Expenses
High-resolution chart · PNG
IMVT r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 142,631,000 | |
| 142,287,000 | |
| 98,924,000 | |
| 114,249,000 | |
| 101,200,000 | |
| 93,651,000 | |
| 94,520,000 | |
| 97,272,000 | |
| 75,473,000 | |
| 66,056,000 | |
| 48,338,000 | |
| 47,959,000 | |
| 50,575,000 | |
| 51,837,000 | |
| 42,252,000 | |
| 37,739,000 | |
| 28,429,000 | |
| 31,986,000 | |
| 29,756,000 | |
| 21,361,000 | |
| 18,705,000 | |
| 18,615,000 | |
| 21,091,000 | |
| 11,976,000 | |
| 16,922,000 | |
| 14,168,000 | |
| 4,953,000 | |
| 10,331,000 | |
| 18,476,000 | |
| 7,969,543 | |
| 7,683,345 | |
| 5,744,881 | |
| 4,335,231 |